- Recommendation ID
- NG23/13
- Question
What is the impact of HRT on health outcomes for trans men and non-binary people registered female at birth (who are not taking gender-affirming hormone therapy at the time of taking HRT or in the follow-up period) in relation to:
-
cardiovascular disease
-
stroke
-
breast, endometrial and ovarian cancer
-
dementia
-
all-cause mortality?
-
- Any explanatory notes
(if applicable) For a short explanation of why the committee made this recommendation for research, see the rationale section on managing menopause in people who have taken gender-affirming hormone therapy in the past
Full details of the evidence and the committee's discussion are in evidence review C: cardiovascular disease and stroke.
Source guidance details
- Comes from guidance
- Menopause: identification and management
- Number
- NG23
- Date issued
- November 2015
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 28/01/2025 |